TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer March 21, 2003
TCL Archive NCI Failed to Publish Two Bypass Budgets As Funds Tightened and Sequestration Set In October 10, 2014
